These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 8608574

  • 21. Double cancer of gall bladder and bile duct not associated with anomalous junction of the pancreaticobiliary duct system.
    Hori H, Ajiki T, Fujita T, Okazaki T, Suzuki Y, Kuroda Y, Fujimori T.
    Jpn J Clin Oncol; 2006 Oct; 36(10):638-42. PubMed ID: 16908513
    [Abstract] [Full Text] [Related]

  • 22. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy.
    Funabiki T, Matsubara T, Miyakawa S, Ishihara S.
    Langenbecks Arch Surg; 2009 Jan; 394(1):159-69. PubMed ID: 18500533
    [Abstract] [Full Text] [Related]

  • 23. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
    Laghi L, Orbetegli O, Bianchi P, Zerbi A, Di Carlo V, Boland CR, Malesci A.
    Oncogene; 2002 Jun 20; 21(27):4301-6. PubMed ID: 12082617
    [Abstract] [Full Text] [Related]

  • 24. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater.
    Matsubayashi H, Watanabe H, Yamaguchi T, Ajioka Y, Nishikura K, Kijima H, Saito T.
    Cancer; 1999 Aug 15; 86(4):596-607. PubMed ID: 10440687
    [Abstract] [Full Text] [Related]

  • 25. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S, Liang Z, Gao J, Wu S, Zhu H, Liu H, Liu T.
    J Gastroenterol Hepatol; 2005 Jan 15; 20(1):67-72. PubMed ID: 15610449
    [Abstract] [Full Text] [Related]

  • 26. Analysis of c-Ki-ras oncogene and p53 immunocytochemistry in the gallbladder mucosa of an experimental dog model of anomalous arrangement of the pancreaticobiliary ducts.
    Sasaki K, Kunitomo K, Yagi K, Masamune K, Komi N, Tashiro S.
    Tokushima J Exp Med; 1996 Dec 15; 43(3-4):101-6. PubMed ID: 9100457
    [Abstract] [Full Text] [Related]

  • 27. Biliary carcinogenesis in pancreaticobiliary maljunction.
    Kamisawa T, Kuruma S, Chiba K, Tabata T, Koizumi S, Kikuyama M.
    J Gastroenterol; 2017 Feb 15; 52(2):158-163. PubMed ID: 27704265
    [Abstract] [Full Text] [Related]

  • 28. Prevalence of RAS point mutations in papillary thyroid carcinoma; a novel mutation at codon 31 of K-RAS.
    Cyniak-Magierska A, Brzeziańska E, Januszkiewicz-Caulier J, Jarzab B, Lewiński A.
    Exp Clin Endocrinol Diabetes; 2007 Oct 15; 115(9):594-9. PubMed ID: 17943694
    [Abstract] [Full Text] [Related]

  • 29. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
    Stork P, Loda M, Bosari S, Wiley B, Poppenhusen K, Wolfe H.
    Oncogene; 1991 May 15; 6(5):857-62. PubMed ID: 1646989
    [Abstract] [Full Text] [Related]

  • 30. High frequency of K-ras mutations in biliary duct carcinomas of cases with a long common channel in the papilla of Vater.
    Hidaka E, Yanagisawa A, Seki M, Takano K, Setoguchi T, Kato Y.
    Cancer Res; 2000 Feb 01; 60(3):522-4. PubMed ID: 10676628
    [Abstract] [Full Text] [Related]

  • 31. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2.
    Przygodzki RM, Finkelstein SD, Keohavong P, Zhu D, Bakker A, Swalsky PA, Soini Y, Ishak KG, Bennett WP.
    Lab Invest; 1997 Jan 01; 76(1):153-9. PubMed ID: 9010458
    [Abstract] [Full Text] [Related]

  • 32. [Frequency of K-ras mutation in biliary and pancreatic tumors].
    Roa JC, Anabalón L, Tapia O, Melo A, de Aretxabala X, Roa I.
    Rev Med Chil; 2005 Dec 01; 133(12):1434-40. PubMed ID: 16446870
    [Abstract] [Full Text] [Related]

  • 33. [Symptoms, diagnosis and treatment of pancreaticobiliary maljunction associated with congenital cystic dilatation of bile duct].
    Funabiki T, Matsubara T, Ochiai M.
    Nihon Geka Gakkai Zasshi; 1996 Aug 01; 97(8):582-8. PubMed ID: 8905805
    [Abstract] [Full Text] [Related]

  • 34. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH, van Mansfeld AD, Offerhaus GJ, van Weering DH, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL.
    Am J Pathol; 1993 Aug 01; 143(2):545-54. PubMed ID: 8342602
    [Abstract] [Full Text] [Related]

  • 35. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
    Lang SM, Heinzlmann M, Stratakis DF, Teschauer W, Loeschke K.
    Am J Gastroenterol; 1997 Dec 01; 92(12):2166-70. PubMed ID: 9399746
    [Abstract] [Full Text] [Related]

  • 36. [K-ras gene mutation in gallbladder carcinoma].
    Roa JC, Roa I, de Aretxabala X, Melo A, Faría G, Tapia O.
    Rev Med Chil; 2004 Aug 01; 132(8):955-60. PubMed ID: 15478297
    [Abstract] [Full Text] [Related]

  • 37. Pancreas divisum in pancreaticobiliary maljunction.
    Kamisawa T, Tu Y, Egawa N, Tsuruta K, Okamoto A, Matsukawa M.
    Hepatogastroenterology; 2008 Aug 01; 55(81):249-53. PubMed ID: 18507118
    [Abstract] [Full Text] [Related]

  • 38. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
    Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE.
    Cancer Res; 1994 Jul 01; 54(13):3568-73. PubMed ID: 8012983
    [Abstract] [Full Text] [Related]

  • 39. K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers.
    Itoi T, Takei K, Shinohara Y, Takeda K, Nakamura K, Horibe T, Sanada A, Ohno H, Matsubayashi H, Saito T, Watanabe H.
    Pathol Int; 1999 Jan 01; 49(1):30-7. PubMed ID: 10227722
    [Abstract] [Full Text] [Related]

  • 40. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.
    Kang YK, Kim WH, Lee HW, Lee HK, Kim YI.
    Lab Invest; 1999 Apr 01; 79(4):477-83. PubMed ID: 10212000
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.